|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Molecular Insight Pharmaceuticals, Inc. (MIPI) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
25,187,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
70,100 |
Avg
Vol: |
31,812 |
| 52
Week Range: |
$0.0041 - $0.0041 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Wallroth Donald E. |
Officer |
– – – |
2009-05-26 |
144 |
NP |
$0.00 |
$24,960 |
/ |
6,500 |
0 |
|
- |
|
| Wallroth Donald E. |
Chief Financial Officer |
• – – |
2009-05-22 |
4 |
S |
$3.75 |
$24,562 |
D/D |
(6,500) |
13,500 |
|
- |
|
| Barlow David S |
Director |
– • • |
2008-12-29 |
4 |
OE |
$1.20 |
$337,496 |
D/D |
81,249 |
2,695,477 |
|
- |
|
| Mccray John E |
Chief Operating Officer |
• – – |
2008-05-20 |
4 |
A |
$0.01 |
$250 |
D/D |
25,000 |
187,103 |
|
- |
|
| Babich John W |
President/Chief Scientific Off |
• • – |
2008-05-20 |
4 |
A |
$0.01 |
$300 |
D/D |
30,000 |
185,906 |
|
- |
|
| Barlow David S |
Chief Executive Officer |
• • • |
2008-05-20 |
4 |
A |
$0.01 |
$500 |
D/D |
50,000 |
2,614,228 |
|
- |
|
| Wallroth Donald E. |
Chief Financial Officer |
• – – |
2008-05-20 |
4 |
A |
$0.01 |
$200 |
D/D |
20,000 |
20,000 |
|
- |
|
| Lafrance Norman D. |
Sr. VP Clinical Dev and CMO |
• – – |
2008-05-20 |
4 |
A |
$0.01 |
$188 |
D/D |
18,750 |
22,750 |
|
- |
|
| Hamermesh Joshua |
VP Comm & Bus Development |
• – – |
2008-03-31 |
4 |
OE |
$3.00 |
$12,498 |
D/D |
4,166 |
20,833 |
|
- |
|
| Hamermesh Joshua |
VP Comm & Bus Development |
• – – |
2008-03-24 |
4 |
OE |
$3.00 |
$25,002 |
D/D |
8,334 |
16,667 |
|
- |
|
| Lafrance Norman D. |
Sr. VP Clinical Dev and CMO |
• – – |
2007-11-30 |
4 |
B |
$8.75 |
$17,557 |
D/D |
2,000 |
4,000 |
2.74 |
- |
|
| Barlow David S |
Chief Executive Officer |
• • • |
2007-11-30 |
4 |
B |
$8.35 |
$42,453 |
D/D |
5,000 |
2,564,227 |
3.23 |
- |
|
| Babich John W |
President/Chief Scientific Off |
• • – |
2007-11-30 |
4 |
B |
$8.34 |
$20,869 |
D/D |
2,500 |
173,535 |
2.81 |
- |
|
| Lafrance Norman D. |
Sr. VP Clinical Dev and CMO |
• – – |
2007-11-29 |
4 |
B |
$7.95 |
$16,090 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
| Frank Daniel |
Director |
– • – |
2007-11-28 |
4 |
OE |
$4.80 |
$20,002 |
D/D |
4,167 |
143,280 |
|
- |
|
| Kronauge James F |
VP Process Development |
• – – |
2007-11-27 |
4 |
B |
$6.50 |
$46 |
D/D |
7 |
48,224 |
2.66 |
- |
|
| Kronauge James F |
VP Process Development |
• – – |
2007-11-26 |
4 |
B |
$6.50 |
$15,594 |
D/D |
2,399 |
48,217 |
2.74 |
- |
|
| Babich John W |
President/Chief Scientific Off |
• • – |
2007-11-20 |
4 |
B |
$6.75 |
$68,585 |
D/D |
10,000 |
171,035 |
2.81 |
- |
|
| Barlow David S |
Chief Executive Officer |
• • • |
2007-11-20 |
4 |
B |
$6.62 |
$101,883 |
D/D |
15,000 |
2,559,228 |
3.23 |
- |
|
| Barlow David S |
Chief Executive Officer |
• • • |
2007-11-08 |
4 |
OE |
$1.20 |
$210,004 |
D/D |
75,001 |
75,001 |
|
- |
|
| Hamermesh Joshua |
VP Comm & Bus Development |
• – – |
2007-06-19 |
4 |
OE |
$3.00 |
$24,999 |
D/D |
8,333 |
8,333 |
|
- |
|
| Feinberg Stephen |
10% Owner |
– – • |
2007-03-30 |
4 |
B |
$12.50 |
$158,025 |
I/I |
12,642 |
3,753,306 |
1.5 |
- |
|
| Feinberg Stephen |
10% Owner |
– – • |
2007-03-29 |
4 |
B |
$12.50 |
$92,612 |
I/I |
7,409 |
3,740,664 |
1.5 |
- |
|
| Feinberg Stephen |
10% Owner |
– – • |
2007-03-28 |
4 |
B |
$12.45 |
$64,747 |
I/I |
5,199 |
3,733,255 |
1.5 |
- |
|
| Babich John W |
President/Chief Scientific Off |
• • – |
2007-02-28 |
4 |
A |
$0.00 |
$0 |
I/I |
49,333 |
49,333 |
|
- |
|
74 Records found
|
|
Page 2 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
